Warby Parker’s shares surged 34.1% following Q1 results that beat expectations on revenue growth and margin resilience, alongside promising execution in scaling omnichannel initiatives and growing eye exams despite challenging seasonal headwinds.
Warby Parker reported a robust Q3 2025, with net revenue growth of 15.2% year-over-year, largely fueled by a 20% increase in retail revenue and a significant improvement in adjusted EBITDA margin.